Xiaobo Cui
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 8
- Cancer-related gene regulation 8
- Epigenetics and DNA Methylation 6
-
- Cancer Genomics and Diagnostics 4
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Co-authors
- Jingxuan Yang (6 shared papers)Xianjun Yu (6 shared papers)Songbin Fu (11 shared papers)Yu‐Qing Zhang (3 shared papers)Huaqing Yan (4 shared papers)Min Li (4 shared papers)Liqi Zhang (1 shared paper)Martín E. Fernández-Zapico (2 shared papers)
- Journals
- International Journal of Oncology (4 papers)Oncotarget (2 papers)Oncology Reports (2 papers)Current Molecular Medicine (2 papers)Journal of Cellular and Molecular Medicine (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaobo Cui
48 papers receiving 856 citations
Peers
Comparison fields: 5 of 96
- Cancer Research 319
- Molecular Biology 574
- Oncology 210
- Nutrition and Dietetics 94
- Immunology and Allergy 36
Countries citing papers authored by Xiaobo Cui
This map shows the geographic impact of Xiaobo Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Cui more than expected).
Fields of papers citing papers by Xiaobo Cui
This network shows the impact of papers produced by Xiaobo Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Cui. The network helps show where Xiaobo Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobo Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 109 | |
| 2 | 2013 | 79 | |
| 3 | 2022 | 52 | |
| 4 | 2013 | 51 | |
| 5 | 2013 | 50 | |
| 6 | 2018 | 49 | |
| 7 | 2008 | 46 | |
| 8 | 2013 | 34 | |
| 9 | 2016 | 28 | |
| 10 | 2014 | 26 | |
| 11 | 2011 | 24 | |
| 12 | 2013 | 24 | |
| 13 | 2011 | 22 | |
| 14 | 2017 | 21 | |
| 15 | 2017 | 20 | |
| 16 | 2012 | 19 | |
| 17 | The E233del mutation in BFSP2 causes a progressive autosomal dominant congenital cataract in a Chinese family. | 2007 | 19 |
| 18 | 2016 | 18 | |
| 19 | 2006 | 17 | |
| 20 | 2019 | 17 |
About Xiaobo Cui
Xiaobo Cui is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 864 indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (6 papers), Cell Adhesion Molecules Research (4 papers), Cancer Genomics and Diagnostics (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Trace Elements in Health (4 papers). The work is most often cited by research in Cancer Research (319 citations), Molecular Biology (574 citations), Oncology (210 citations), Nutrition and Dietetics (94 citations) and Immunology and Allergy (36 citations). Xiaobo Cui has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jingxuan Yang, Xianjun Yu, Songbin Fu, Yu‐Qing Zhang, Huaqing Yan, Min Li, Liqi Zhang, Martín E. Fernández-Zapico, Xiangning Meng and Jiang Long. Their work appears in journals such as International Journal of Oncology, Oncotarget, Oncology Reports, Current Molecular Medicine and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.